Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1989 Apr;57(4):1078–1083. doi: 10.1128/iai.57.4.1078-1083.1989

Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates.

A F Verheul 1, A A Versteeg 1, M J De Reuver 1, M Jansze 1, H Snippe 1
PMCID: PMC313232  PMID: 2925240

Abstract

Streptococcus pneumoniae type 14 capsular polysaccharide-bovine serum albumin (S14PS-BSA) conjugates were prepared by water-soluble-carbodiimide-mediated condensation with or without the use of N-hydroxy-sulfosuccinimide. The immunogenicities of the capsular polysaccharide (S14PS) and of the conjugates were studied in (CBA/N x BALB/c)F1 mice and in female BALB/c mice. The response in these mice indicates that S14PS could be classified as a thymus-independent type 2 antigen. Coupling of S14PS to BSA improved the immunogenicity of this polysaccharide, and an immunoglobulin G memory response was evoked. Conjugation with N-hydroxysulfosuccinimide resulted in a product with a higher polysaccharide/protein ratio. This conjugate induced a greater immune response than did the classical conjugate. Quil A enhanced the immune response to S14PS and to most S14PS-BSA conjugates. The enhancement of the immune response to the conjugates seemed to depend on the coupling procedure. Our results indicate that for the construction of immunostimulating complexes based on polysaccharide or oligosaccharide-protein conjugates, attention should be paid to the degree of cross-linking of the antigens involved.

Full text

PDF
1078

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aplin J. D., Wriston J. C., Jr Preparation, properties, and applications of carbohydrate conjugates of proteins and lipids. CRC Crit Rev Biochem. 1981;10(4):259–306. doi: 10.3109/10409238109113601. [DOI] [PubMed] [Google Scholar]
  2. Austrian R. Polysaccharide vaccines. Ann Inst Pasteur Microbiol. 1985 Nov-Dec;136B(3):295–307. doi: 10.1016/s0769-2609(85)80075-2. [DOI] [PubMed] [Google Scholar]
  3. Austrian R. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev Infect Dis. 1981 Mar-Apr;3 (Suppl):S1–17. doi: 10.1093/clinids/3.supplement_1.s1. [DOI] [PubMed] [Google Scholar]
  4. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  5. Campbell J. H., Pappenheimer A. M., Jr Quantitative studies of the specificity of anti-pneumococcal polysaccharide antibodies, types 3 and 8. I. Isolation of oligosaccharides from acid and from enzymatic hydrolysates of S3 and S8. Immunochemistry. 1966 May;3(3):195–212. doi: 10.1016/0019-2791(66)90184-4. [DOI] [PubMed] [Google Scholar]
  6. Chavali S. R., Campbell J. B. Adjuvant effects of orally administered saponins on humoral and cellular immune responses in mice. Immunobiology. 1987 May;174(3):347–359. doi: 10.1016/s0171-2985(87)80009-8. [DOI] [PubMed] [Google Scholar]
  7. Flebbe L. M., Braley-Mullen H. Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T-dependent and T-independent antigens. Cell Immunol. 1986 Apr 15;99(1):119–127. doi: 10.1016/0008-8749(86)90221-2. [DOI] [PubMed] [Google Scholar]
  8. Flebbe L. M., Braley-Mullen H. Immunopotentiation by SGP and Quil A. II. Identification of responding cell populations. Cell Immunol. 1986 Apr 15;99(1):128–139. doi: 10.1016/0008-8749(86)90222-4. [DOI] [PubMed] [Google Scholar]
  9. Griffiss J. M., Apicella M. A., Greenwood B., Mäkelä P. H. Vaccines against encapsulated bacteria: a global agenda. Rev Infect Dis. 1987 Jan-Feb;9(1):176–188. doi: 10.1093/clinids/9.1.176. [DOI] [PubMed] [Google Scholar]
  10. Kamerling J. P., Gerwig G. J., Vliegenthart J. F., Clamp J. R. Characterization by gas-liquid chromatography-mass spectrometry and proton-magnetic-resonance spectroscopy of pertrimethylsilyl methyl glycosides obtained in the methanolysis of glycoproteins and glycopeptides. Biochem J. 1975 Dec;151(3):491–495. doi: 10.1042/bj1510491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kemp H. A., Morgan M. R. Studies on the detrimental effects of bivalent binding in a microtitration plate ELISA and possible remedies. J Immunol Methods. 1986 Nov 20;94(1-2):65–72. doi: 10.1016/0022-1759(86)90216-4. [DOI] [PubMed] [Google Scholar]
  12. Käyhty H., Eskola J., Peltola H., Stout M. G., Samuelson J. S., Gordon L. K. Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid. J Infect Dis. 1987 Jan;155(1):100–106. doi: 10.1093/infdis/155.1.100. [DOI] [PubMed] [Google Scholar]
  13. Lee C. J. Bacterial capsular polysaccharides--biochemistry, immunity and vaccine. Mol Immunol. 1987 Oct;24(10):1005–1019. doi: 10.1016/0161-5890(87)90067-8. [DOI] [PubMed] [Google Scholar]
  14. Lee C. J., Takaoka Y., Saito T. Maternal immunization and the immune response of neonates to pneumococcal polysaccharides. Rev Infect Dis. 1987 May-Jun;9(3):494–510. doi: 10.1093/clinids/9.3.494. [DOI] [PubMed] [Google Scholar]
  15. Leinikki P. O., Shekarchi I., Dorsett P., Sever J. L. Enzyme-linked immunosorbent assay determination of specific rubella antibody levels in micrograms of immunoglobulin G per milliliter of serum in clinical samples. J Clin Microbiol. 1978 Oct;8(4):419–423. doi: 10.1128/jcm.8.4.419-423.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Leinonen M., Säkkinen A., Kalliokoski R., Luotonen J., Timonen M., Mäkelä P. H. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis. 1986 Jan-Feb;5(1):39–44. doi: 10.1097/00006454-198601000-00008. [DOI] [PubMed] [Google Scholar]
  17. Lin K. T., Lee C. J. Immune response of neonates to pneumococcal polysaccharide-protein conjugate. Immunology. 1982 Jun;46(2):333–342. [PMC free article] [PubMed] [Google Scholar]
  18. McCormick D. B., Roth J. A. Specificity, stereochemistry, and mechanism of the color reaction between p-dimethylaminocinnamalhyde and biotin analogs. Anal Biochem. 1970 Mar;34:226–236. doi: 10.1016/0003-2697(70)90102-8. [DOI] [PubMed] [Google Scholar]
  19. Morein B. Immunopotentiating complexes. Acta Trop Suppl. 1987 Jun;12:98–103. [PubMed] [Google Scholar]
  20. Robbins J. B., Austrian R., Lee C. J., Rastogi S. C., Schiffman G., Henrichsen J., Mäkelä P. H., Broome C. V., Facklam R. R., Tiesjema R. H. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis. 1983 Dec;148(6):1136–1159. doi: 10.1093/infdis/148.6.1136. [DOI] [PubMed] [Google Scholar]
  21. Schneerson R., Barrera O., Sutton A., Robbins J. B. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med. 1980 Aug 1;152(2):361–376. doi: 10.1084/jem.152.2.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schneerson R., Robbins J. B., Parke J. C., Jr, Bell C., Schlesselman J. J., Sutton A., Wang Z., Schiffman G., Karpas A., Shiloach J. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect Immun. 1986 May;52(2):519–528. doi: 10.1128/iai.52.2.519-528.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Staros J. V., Wright R. W., Swingle D. M. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal Biochem. 1986 Jul;156(1):220–222. doi: 10.1016/0003-2697(86)90176-4. [DOI] [PubMed] [Google Scholar]
  24. Sutton A., Vann W. F., Karpas A. B., Stein K. E., Schneerson R. An avidin-biotin based ELISA for quantitation of antibody to bacterial polysaccharides. J Immunol Methods. 1985 Oct 10;82(2):215–224. doi: 10.1016/0022-1759(85)90353-9. [DOI] [PubMed] [Google Scholar]
  25. Svenson S. B., Lindberg A. A. Artificial Salmonella vaccines. Prog Allergy. 1983;33:120–143. doi: 10.1159/000407424. [DOI] [PubMed] [Google Scholar]
  26. Tai J. Y., Vella P. P., McLean A. A., Woodhour A. F., McAleer W. J., Sha A., Dennis-Sykes C., Hilleman M. R. Haemophilus influenzae type b polysaccharide-protein conjugate vaccine. Proc Soc Exp Biol Med. 1987 Feb;184(2):154–161. doi: 10.3181/00379727-184-42460. [DOI] [PubMed] [Google Scholar]
  27. Wicker L. S., Scher I. X-linked immune deficiency (xid) of CBA/N mice. Curr Top Microbiol Immunol. 1986;124:87–101. doi: 10.1007/978-3-642-70986-9_6. [DOI] [PubMed] [Google Scholar]
  28. Zigterman J. W., van Dam J. E., Snippe H., Rotteveel F. T., Jansze M., Willers J. M., Kamerling J. P., Vliegenthart J. F. Immunogenic properties of octasaccharide-protein conjugates derived from Klebsiella serotype 11 capsular polysaccharide. Infect Immun. 1985 Feb;47(2):421–428. doi: 10.1128/iai.47.2.421-428.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES